nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—ALB—Vismodegib—skin cancer	0.0887	0.121	CbGbCtD
Phenytoin—ALB—Vemurafenib—skin cancer	0.0701	0.0953	CbGbCtD
Phenytoin—CYP2C8—Vismodegib—skin cancer	0.0686	0.0932	CbGbCtD
Phenytoin—CYP2C19—Vismodegib—skin cancer	0.0575	0.0781	CbGbCtD
Phenytoin—CYP2C9—Vismodegib—skin cancer	0.0478	0.065	CbGbCtD
Phenytoin—ABCB1—Vismodegib—skin cancer	0.0464	0.0631	CbGbCtD
Phenytoin—CYP3A4—Imiquimod—skin cancer	0.0401	0.0545	CbGbCtD
Phenytoin—CYP3A4—Temozolomide—skin cancer	0.0401	0.0545	CbGbCtD
Phenytoin—ABCC2—Docetaxel—skin cancer	0.0386	0.0525	CbGbCtD
Phenytoin—ALB—Fluorouracil—skin cancer	0.0315	0.0428	CbGbCtD
Phenytoin—CYP3A4—Vismodegib—skin cancer	0.0278	0.0378	CbGbCtD
Phenytoin—CYP3A7—Docetaxel—skin cancer	0.0258	0.035	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0258	0.035	CbGbCtD
Phenytoin—ABCB1—Dactinomycin—skin cancer	0.0244	0.0331	CbGbCtD
Phenytoin—CYP2C8—Fluorouracil—skin cancer	0.0244	0.0331	CbGbCtD
Phenytoin—CYP3A4—Vemurafenib—skin cancer	0.022	0.0299	CbGbCtD
Phenytoin—CYP3A5—Docetaxel—skin cancer	0.0193	0.0263	CbGbCtD
Phenytoin—CYP2C9—Fluorouracil—skin cancer	0.017	0.0231	CbGbCtD
Phenytoin—ABCB1—Docetaxel—skin cancer	0.0126	0.0171	CbGbCtD
Phenytoin—CYP3A4—Docetaxel—skin cancer	0.00754	0.0102	CbGbCtD
Phenytoin—SCN8A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00267	0.083	CbGpPWpGaD
Phenytoin—SCN9A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00216	0.0671	CbGpPWpGaD
Phenytoin—SCN3A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00207	0.0642	CbGpPWpGaD
Phenytoin—SCN4A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00199	0.0617	CbGpPWpGaD
Phenytoin—SCN2A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00199	0.0617	CbGpPWpGaD
Phenytoin—SCN1A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00192	0.0595	CbGpPWpGaD
Phenytoin—SCN5A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00135	0.0418	CbGpPWpGaD
Phenytoin—SCN8A—L1CAM interactions—SCN10A—skin cancer	0.00103	0.0319	CbGpPWpGaD
Phenytoin—SCN9A—L1CAM interactions—SCN10A—skin cancer	0.00083	0.0258	CbGpPWpGaD
Phenytoin—SCN3A—L1CAM interactions—SCN10A—skin cancer	0.000794	0.0246	CbGpPWpGaD
Phenytoin—SCN2A—L1CAM interactions—SCN10A—skin cancer	0.000762	0.0237	CbGpPWpGaD
Phenytoin—SCN4A—L1CAM interactions—SCN10A—skin cancer	0.000762	0.0237	CbGpPWpGaD
Phenytoin—CYP11B1—Corticotropin-releasing hormone—KRT14—skin cancer	0.000739	0.0229	CbGpPWpGaD
Phenytoin—SCN1A—L1CAM interactions—SCN10A—skin cancer	0.000735	0.0228	CbGpPWpGaD
Phenytoin—SCN5A—L1CAM interactions—SCN10A—skin cancer	0.000517	0.016	CbGpPWpGaD
Phenytoin—CYP2C18—FOXA1 transcription factor network—SHH—skin cancer	0.000508	0.0158	CbGpPWpGaD
Phenytoin—SLCO1C1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000404	0.0125	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—SCN10A—skin cancer	0.000388	0.012	CbGpPWpGaD
Phenytoin—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—skin cancer	0.000364	0.0113	CbGpPWpGaD
Phenytoin—Dyspepsia—Imiquimod—skin cancer	0.000351	0.00152	CcSEcCtD
Phenytoin—Pneumonia—Fluorouracil—skin cancer	0.000347	0.0015	CcSEcCtD
Phenytoin—Decreased appetite—Imiquimod—skin cancer	0.000347	0.0015	CcSEcCtD
Phenytoin—Hypersensitivity—Vemurafenib—skin cancer	0.000345	0.00149	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Imiquimod—skin cancer	0.000344	0.00149	CcSEcCtD
Phenytoin—Fatigue—Imiquimod—skin cancer	0.000344	0.00149	CcSEcCtD
Phenytoin—Haemoglobin—Temozolomide—skin cancer	0.000338	0.00146	CcSEcCtD
Phenytoin—Haemorrhage—Temozolomide—skin cancer	0.000336	0.00145	CcSEcCtD
Phenytoin—Conjunctivitis—Fluorouracil—skin cancer	0.000336	0.00145	CcSEcCtD
Phenytoin—Asthenia—Vemurafenib—skin cancer	0.000336	0.00145	CcSEcCtD
Phenytoin—Hypoaesthesia—Temozolomide—skin cancer	0.000335	0.00145	CcSEcCtD
Phenytoin—Pharyngitis—Temozolomide—skin cancer	0.000334	0.00144	CcSEcCtD
Phenytoin—Chills—Dactinomycin—skin cancer	0.000334	0.00144	CcSEcCtD
Phenytoin—Pruritus—Vemurafenib—skin cancer	0.000331	0.00143	CcSEcCtD
Phenytoin—Connective tissue disorder—Temozolomide—skin cancer	0.000331	0.00143	CcSEcCtD
Phenytoin—Feeling abnormal—Imiquimod—skin cancer	0.000329	0.00142	CcSEcCtD
Phenytoin—Epistaxis—Fluorouracil—skin cancer	0.000326	0.00141	CcSEcCtD
Phenytoin—Sinusitis—Fluorouracil—skin cancer	0.000324	0.0014	CcSEcCtD
Phenytoin—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000323	0.0014	CcSEcCtD
Phenytoin—Agranulocytosis—Fluorouracil—skin cancer	0.000322	0.00139	CcSEcCtD
Phenytoin—Ill-defined disorder—Bleomycin—skin cancer	0.000322	0.00139	CcSEcCtD
Phenytoin—Anaemia—Bleomycin—skin cancer	0.000321	0.00139	CcSEcCtD
Phenytoin—Diarrhoea—Vemurafenib—skin cancer	0.00032	0.00138	CcSEcCtD
Phenytoin—Migraine—Docetaxel—skin cancer	0.000318	0.00137	CcSEcCtD
Phenytoin—Erythema multiforme—Temozolomide—skin cancer	0.000318	0.00137	CcSEcCtD
Phenytoin—Urticaria—Imiquimod—skin cancer	0.000317	0.00137	CcSEcCtD
Phenytoin—Body temperature increased—Imiquimod—skin cancer	0.000315	0.00136	CcSEcCtD
Phenytoin—Tinnitus—Temozolomide—skin cancer	0.000314	0.00135	CcSEcCtD
Phenytoin—SCN9A—Axon guidance—SCN10A—skin cancer	0.000314	0.00974	CbGpPWpGaD
Phenytoin—Malaise—Bleomycin—skin cancer	0.000313	0.00135	CcSEcCtD
Phenytoin—Haemoglobin—Fluorouracil—skin cancer	0.000312	0.00135	CcSEcCtD
Phenytoin—Leukopenia—Bleomycin—skin cancer	0.000311	0.00134	CcSEcCtD
Phenytoin—Rhinitis—Fluorouracil—skin cancer	0.000311	0.00134	CcSEcCtD
Phenytoin—Haemorrhage—Fluorouracil—skin cancer	0.00031	0.00134	CcSEcCtD
Phenytoin—Dizziness—Vemurafenib—skin cancer	0.000309	0.00134	CcSEcCtD
Phenytoin—Hypoaesthesia—Fluorouracil—skin cancer	0.000308	0.00133	CcSEcCtD
Phenytoin—Pharyngitis—Fluorouracil—skin cancer	0.000308	0.00133	CcSEcCtD
Phenytoin—Ataxia—Docetaxel—skin cancer	0.000304	0.00131	CcSEcCtD
Phenytoin—Immune system disorder—Temozolomide—skin cancer	0.000304	0.00131	CcSEcCtD
Phenytoin—Cough—Bleomycin—skin cancer	0.000303	0.00131	CcSEcCtD
Phenytoin—Chills—Temozolomide—skin cancer	0.000302	0.0013	CcSEcCtD
Phenytoin—Dehydration—Docetaxel—skin cancer	0.000301	0.0013	CcSEcCtD
Phenytoin—Ill-defined disorder—Dactinomycin—skin cancer	0.0003	0.0013	CcSEcCtD
Phenytoin—SCN3A—Axon guidance—SCN10A—skin cancer	0.0003	0.00931	CbGpPWpGaD
Phenytoin—Anaemia—Dactinomycin—skin cancer	0.000299	0.00129	CcSEcCtD
Phenytoin—Liver function test abnormal—Docetaxel—skin cancer	0.000299	0.00129	CcSEcCtD
Phenytoin—Vomiting—Vemurafenib—skin cancer	0.000297	0.00128	CcSEcCtD
Phenytoin—Myalgia—Bleomycin—skin cancer	0.000296	0.00128	CcSEcCtD
Phenytoin—Chest pain—Bleomycin—skin cancer	0.000296	0.00128	CcSEcCtD
Phenytoin—Orthostatic hypotension—Docetaxel—skin cancer	0.000295	0.00128	CcSEcCtD
Phenytoin—Abdominal pain upper—Docetaxel—skin cancer	0.000295	0.00128	CcSEcCtD
Phenytoin—Rash—Vemurafenib—skin cancer	0.000295	0.00127	CcSEcCtD
Phenytoin—Dermatitis—Vemurafenib—skin cancer	0.000295	0.00127	CcSEcCtD
Phenytoin—Hypersensitivity—Imiquimod—skin cancer	0.000294	0.00127	CcSEcCtD
Phenytoin—Headache—Vemurafenib—skin cancer	0.000293	0.00127	CcSEcCtD
Phenytoin—Breast disorder—Docetaxel—skin cancer	0.000292	0.00126	CcSEcCtD
Phenytoin—Discomfort—Bleomycin—skin cancer	0.000292	0.00126	CcSEcCtD
Phenytoin—Malaise—Dactinomycin—skin cancer	0.000292	0.00126	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000291	0.00126	CcSEcCtD
Phenytoin—Leukopenia—Dactinomycin—skin cancer	0.00029	0.00125	CcSEcCtD
Phenytoin—SCN2A—Axon guidance—SCN10A—skin cancer	0.000288	0.00895	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—SCN10A—skin cancer	0.000288	0.00895	CbGpPWpGaD
Phenytoin—Dysgeusia—Temozolomide—skin cancer	0.000287	0.00124	CcSEcCtD
Phenytoin—Asthenia—Imiquimod—skin cancer	0.000286	0.00124	CcSEcCtD
Phenytoin—Confusional state—Bleomycin—skin cancer	0.000286	0.00123	CcSEcCtD
Phenytoin—Anaphylactic shock—Bleomycin—skin cancer	0.000283	0.00122	CcSEcCtD
Phenytoin—Back pain—Temozolomide—skin cancer	0.000283	0.00122	CcSEcCtD
Phenytoin—Pruritus—Imiquimod—skin cancer	0.000282	0.00122	CcSEcCtD
Phenytoin—Infection—Bleomycin—skin cancer	0.000281	0.00122	CcSEcCtD
Phenytoin—Dysphagia—Docetaxel—skin cancer	0.00028	0.00121	CcSEcCtD
Phenytoin—SCN1A—Axon guidance—SCN10A—skin cancer	0.000278	0.00863	CbGpPWpGaD
Phenytoin—Nausea—Vemurafenib—skin cancer	0.000278	0.0012	CcSEcCtD
Phenytoin—Thrombocytopenia—Bleomycin—skin cancer	0.000277	0.0012	CcSEcCtD
Phenytoin—SCN8A—Developmental Biology—SCN10A—skin cancer	0.000277	0.00859	CbGpPWpGaD
Phenytoin—Myalgia—Dactinomycin—skin cancer	0.000276	0.00119	CcSEcCtD
Phenytoin—Tremor—Temozolomide—skin cancer	0.000274	0.00119	CcSEcCtD
Phenytoin—Diarrhoea—Imiquimod—skin cancer	0.000273	0.00118	CcSEcCtD
Phenytoin—Discomfort—Dactinomycin—skin cancer	0.000272	0.00118	CcSEcCtD
Phenytoin—Ill-defined disorder—Temozolomide—skin cancer	0.000272	0.00117	CcSEcCtD
Phenytoin—Anaemia—Temozolomide—skin cancer	0.000271	0.00117	CcSEcCtD
Phenytoin—Anorexia—Bleomycin—skin cancer	0.00027	0.00117	CcSEcCtD
Phenytoin—Agitation—Temozolomide—skin cancer	0.000269	0.00116	CcSEcCtD
Phenytoin—Pancytopenia—Docetaxel—skin cancer	0.000265	0.00115	CcSEcCtD
Phenytoin—Hypotension—Bleomycin—skin cancer	0.000265	0.00114	CcSEcCtD
Phenytoin—Malaise—Temozolomide—skin cancer	0.000264	0.00114	CcSEcCtD
Phenytoin—Dizziness—Imiquimod—skin cancer	0.000264	0.00114	CcSEcCtD
Phenytoin—Vertigo—Temozolomide—skin cancer	0.000263	0.00114	CcSEcCtD
Phenytoin—Infection—Dactinomycin—skin cancer	0.000263	0.00113	CcSEcCtD
Phenytoin—Leukopenia—Temozolomide—skin cancer	0.000262	0.00113	CcSEcCtD
Phenytoin—Palpitations—Temozolomide—skin cancer	0.000259	0.00112	CcSEcCtD
Phenytoin—Thrombocytopenia—Dactinomycin—skin cancer	0.000259	0.00112	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000258	0.00112	CcSEcCtD
Phenytoin—Cough—Temozolomide—skin cancer	0.000256	0.0011	CcSEcCtD
Phenytoin—Paraesthesia—Bleomycin—skin cancer	0.000254	0.0011	CcSEcCtD
Phenytoin—Convulsion—Temozolomide—skin cancer	0.000254	0.0011	CcSEcCtD
Phenytoin—Vomiting—Imiquimod—skin cancer	0.000254	0.0011	CcSEcCtD
Phenytoin—Weight decreased—Docetaxel—skin cancer	0.000253	0.00109	CcSEcCtD
Phenytoin—Hypertension—Temozolomide—skin cancer	0.000253	0.00109	CcSEcCtD
Phenytoin—Dyspnoea—Bleomycin—skin cancer	0.000253	0.00109	CcSEcCtD
Phenytoin—Anorexia—Dactinomycin—skin cancer	0.000252	0.00109	CcSEcCtD
Phenytoin—Rash—Imiquimod—skin cancer	0.000251	0.00109	CcSEcCtD
Phenytoin—Dermatitis—Imiquimod—skin cancer	0.000251	0.00109	CcSEcCtD
Phenytoin—Pneumonia—Docetaxel—skin cancer	0.000251	0.00108	CcSEcCtD
Phenytoin—Headache—Imiquimod—skin cancer	0.00025	0.00108	CcSEcCtD
Phenytoin—Anaemia—Fluorouracil—skin cancer	0.000249	0.00108	CcSEcCtD
Phenytoin—Myalgia—Temozolomide—skin cancer	0.000249	0.00108	CcSEcCtD
Phenytoin—Arthralgia—Temozolomide—skin cancer	0.000249	0.00108	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000247	0.00107	CcSEcCtD
Phenytoin—Discomfort—Temozolomide—skin cancer	0.000246	0.00106	CcSEcCtD
Phenytoin—Decreased appetite—Bleomycin—skin cancer	0.000246	0.00106	CcSEcCtD
Phenytoin—Renal failure—Docetaxel—skin cancer	0.000245	0.00106	CcSEcCtD
Phenytoin—Dry mouth—Temozolomide—skin cancer	0.000244	0.00105	CcSEcCtD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000243	0.00755	CbGpPWpGaD
Phenytoin—Conjunctivitis—Docetaxel—skin cancer	0.000242	0.00105	CcSEcCtD
Phenytoin—Leukopenia—Fluorouracil—skin cancer	0.000242	0.00104	CcSEcCtD
Phenytoin—Confusional state—Temozolomide—skin cancer	0.000241	0.00104	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000241	0.00104	CcSEcCtD
Phenytoin—Anaphylactic shock—Temozolomide—skin cancer	0.000239	0.00103	CcSEcCtD
Phenytoin—Infection—Temozolomide—skin cancer	0.000237	0.00103	CcSEcCtD
Phenytoin—Nausea—Imiquimod—skin cancer	0.000237	0.00102	CcSEcCtD
Phenytoin—Hepatobiliary disease—Docetaxel—skin cancer	0.000236	0.00102	CcSEcCtD
Phenytoin—Epistaxis—Docetaxel—skin cancer	0.000235	0.00102	CcSEcCtD
Phenytoin—Nervous system disorder—Temozolomide—skin cancer	0.000234	0.00101	CcSEcCtD
Phenytoin—Thrombocytopenia—Temozolomide—skin cancer	0.000234	0.00101	CcSEcCtD
Phenytoin—Convulsion—Fluorouracil—skin cancer	0.000234	0.00101	CcSEcCtD
Phenytoin—Feeling abnormal—Bleomycin—skin cancer	0.000233	0.00101	CcSEcCtD
Phenytoin—Agranulocytosis—Docetaxel—skin cancer	0.000233	0.001	CcSEcCtD
Phenytoin—Hyperhidrosis—Temozolomide—skin cancer	0.000231	0.000998	CcSEcCtD
Phenytoin—Chest pain—Fluorouracil—skin cancer	0.00023	0.000992	CcSEcCtD
Phenytoin—Myalgia—Fluorouracil—skin cancer	0.00023	0.000992	CcSEcCtD
Phenytoin—Decreased appetite—Dactinomycin—skin cancer	0.00023	0.000992	CcSEcCtD
Phenytoin—Fatigue—Dactinomycin—skin cancer	0.000228	0.000984	CcSEcCtD
Phenytoin—Anorexia—Temozolomide—skin cancer	0.000228	0.000984	CcSEcCtD
Phenytoin—Discomfort—Fluorouracil—skin cancer	0.000227	0.00098	CcSEcCtD
Phenytoin—Urticaria—Bleomycin—skin cancer	0.000225	0.000972	CcSEcCtD
Phenytoin—Haemoglobin—Docetaxel—skin cancer	0.000225	0.000971	CcSEcCtD
Phenytoin—Rhinitis—Docetaxel—skin cancer	0.000224	0.000969	CcSEcCtD
Phenytoin—Body temperature increased—Bleomycin—skin cancer	0.000224	0.000967	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—SCN10A—skin cancer	0.000224	0.00695	CbGpPWpGaD
Phenytoin—Haemorrhage—Docetaxel—skin cancer	0.000224	0.000966	CcSEcCtD
Phenytoin—SCN8A—Axon guidance—RASA1—skin cancer	0.000223	0.00691	CbGpPWpGaD
Phenytoin—Hypoaesthesia—Docetaxel—skin cancer	0.000223	0.000961	CcSEcCtD
Phenytoin—Confusional state—Fluorouracil—skin cancer	0.000222	0.000959	CcSEcCtD
Phenytoin—Pharyngitis—Docetaxel—skin cancer	0.000222	0.000959	CcSEcCtD
Phenytoin—Anaphylactic shock—Fluorouracil—skin cancer	0.00022	0.000951	CcSEcCtD
Phenytoin—Connective tissue disorder—Docetaxel—skin cancer	0.00022	0.00095	CcSEcCtD
Phenytoin—Infection—Fluorouracil—skin cancer	0.000219	0.000945	CcSEcCtD
Phenytoin—Feeling abnormal—Dactinomycin—skin cancer	0.000218	0.000941	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000218	0.000941	CcSEcCtD
Phenytoin—Insomnia—Temozolomide—skin cancer	0.000216	0.000934	CcSEcCtD
Phenytoin—Nervous system disorder—Fluorouracil—skin cancer	0.000216	0.000933	CcSEcCtD
Phenytoin—Thrombocytopenia—Fluorouracil—skin cancer	0.000216	0.000931	CcSEcCtD
Phenytoin—Tachycardia—Fluorouracil—skin cancer	0.000215	0.000928	CcSEcCtD
Phenytoin—Paraesthesia—Temozolomide—skin cancer	0.000215	0.000927	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—SCN10A—skin cancer	0.000214	0.00664	CbGpPWpGaD
Phenytoin—Dyspnoea—Temozolomide—skin cancer	0.000213	0.00092	CcSEcCtD
Phenytoin—Somnolence—Temozolomide—skin cancer	0.000212	0.000918	CcSEcCtD
Phenytoin—Erythema multiforme—Docetaxel—skin cancer	0.000212	0.000914	CcSEcCtD
Phenytoin—Dyspepsia—Temozolomide—skin cancer	0.00021	0.000909	CcSEcCtD
Phenytoin—Anorexia—Fluorouracil—skin cancer	0.00021	0.000907	CcSEcCtD
Phenytoin—Body temperature increased—Dactinomycin—skin cancer	0.000209	0.000902	CcSEcCtD
Phenytoin—Hypersensitivity—Bleomycin—skin cancer	0.000209	0.000902	CcSEcCtD
Phenytoin—Decreased appetite—Temozolomide—skin cancer	0.000208	0.000897	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Temozolomide—skin cancer	0.000206	0.000891	CcSEcCtD
Phenytoin—Fatigue—Temozolomide—skin cancer	0.000206	0.00089	CcSEcCtD
Phenytoin—Hypotension—Fluorouracil—skin cancer	0.000206	0.000889	CcSEcCtD
Phenytoin—SCN2A—Developmental Biology—SCN10A—skin cancer	0.000206	0.00638	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—SCN10A—skin cancer	0.000206	0.00638	CbGpPWpGaD
Phenytoin—SLCO1C1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000205	0.00638	CbGpPWpGaD
Phenytoin—Constipation—Temozolomide—skin cancer	0.000204	0.000883	CcSEcCtD
Phenytoin—Asthenia—Bleomycin—skin cancer	0.000203	0.000878	CcSEcCtD
Phenytoin—Immune system disorder—Docetaxel—skin cancer	0.000202	0.000873	CcSEcCtD
Phenytoin—Chills—Docetaxel—skin cancer	0.000201	0.000867	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000201	0.000867	CcSEcCtD
Phenytoin—Pruritus—Bleomycin—skin cancer	0.0002	0.000866	CcSEcCtD
Phenytoin—Insomnia—Fluorouracil—skin cancer	0.000199	0.00086	CcSEcCtD
Phenytoin—SCN1A—Developmental Biology—SCN10A—skin cancer	0.000198	0.00616	CbGpPWpGaD
Phenytoin—Paraesthesia—Fluorouracil—skin cancer	0.000198	0.000854	CcSEcCtD
Phenytoin—Feeling abnormal—Temozolomide—skin cancer	0.000197	0.000851	CcSEcCtD
Phenytoin—Dyspnoea—Fluorouracil—skin cancer	0.000196	0.000848	CcSEcCtD
Phenytoin—Somnolence—Fluorouracil—skin cancer	0.000196	0.000846	CcSEcCtD
Phenytoin—SCN5A—Axon guidance—SCN10A—skin cancer	0.000195	0.00606	CbGpPWpGaD
Phenytoin—Hypersensitivity—Dactinomycin—skin cancer	0.000195	0.000841	CcSEcCtD
Phenytoin—Dyspepsia—Fluorouracil—skin cancer	0.000194	0.000837	CcSEcCtD
Phenytoin—Decreased appetite—Fluorouracil—skin cancer	0.000191	0.000827	CcSEcCtD
Phenytoin—Dysgeusia—Docetaxel—skin cancer	0.000191	0.000824	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00019	0.000821	CcSEcCtD
Phenytoin—Urticaria—Temozolomide—skin cancer	0.00019	0.00082	CcSEcCtD
Phenytoin—Asthenia—Dactinomycin—skin cancer	0.00019	0.000819	CcSEcCtD
Phenytoin—Body temperature increased—Temozolomide—skin cancer	0.000189	0.000816	CcSEcCtD
Phenytoin—Back pain—Docetaxel—skin cancer	0.000188	0.000814	CcSEcCtD
Phenytoin—Muscle spasms—Docetaxel—skin cancer	0.000187	0.000809	CcSEcCtD
Phenytoin—Feeling abnormal—Fluorouracil—skin cancer	0.000181	0.000784	CcSEcCtD
Phenytoin—Diarrhoea—Dactinomycin—skin cancer	0.000181	0.000781	CcSEcCtD
Phenytoin—Vomiting—Bleomycin—skin cancer	0.00018	0.000778	CcSEcCtD
Phenytoin—SCN9A—Axon guidance—RASA1—skin cancer	0.00018	0.00559	CbGpPWpGaD
Phenytoin—Anaemia—Docetaxel—skin cancer	0.00018	0.000778	CcSEcCtD
Phenytoin—Rash—Bleomycin—skin cancer	0.000179	0.000772	CcSEcCtD
Phenytoin—Dermatitis—Bleomycin—skin cancer	0.000178	0.000771	CcSEcCtD
Phenytoin—Hypersensitivity—Temozolomide—skin cancer	0.000176	0.000761	CcSEcCtD
Phenytoin—Urticaria—Fluorouracil—skin cancer	0.000175	0.000756	CcSEcCtD
Phenytoin—Syncope—Docetaxel—skin cancer	0.000175	0.000754	CcSEcCtD
Phenytoin—Leukopenia—Docetaxel—skin cancer	0.000174	0.000753	CcSEcCtD
Phenytoin—Body temperature increased—Fluorouracil—skin cancer	0.000174	0.000752	CcSEcCtD
Phenytoin—SCN3A—Axon guidance—RASA1—skin cancer	0.000172	0.00535	CbGpPWpGaD
Phenytoin—Palpitations—Docetaxel—skin cancer	0.000172	0.000743	CcSEcCtD
Phenytoin—Asthenia—Temozolomide—skin cancer	0.000171	0.000741	CcSEcCtD
Phenytoin—Loss of consciousness—Docetaxel—skin cancer	0.000171	0.000739	CcSEcCtD
Phenytoin—Cough—Docetaxel—skin cancer	0.00017	0.000734	CcSEcCtD
Phenytoin—Pruritus—Temozolomide—skin cancer	0.000169	0.00073	CcSEcCtD
Phenytoin—Convulsion—Docetaxel—skin cancer	0.000169	0.000729	CcSEcCtD
Phenytoin—Nausea—Bleomycin—skin cancer	0.000168	0.000727	CcSEcCtD
Phenytoin—Hypertension—Docetaxel—skin cancer	0.000168	0.000726	CcSEcCtD
Phenytoin—Vomiting—Dactinomycin—skin cancer	0.000168	0.000726	CcSEcCtD
Phenytoin—Rash—Dactinomycin—skin cancer	0.000167	0.00072	CcSEcCtD
Phenytoin—Chest pain—Docetaxel—skin cancer	0.000166	0.000716	CcSEcCtD
Phenytoin—Myalgia—Docetaxel—skin cancer	0.000166	0.000716	CcSEcCtD
Phenytoin—Arthralgia—Docetaxel—skin cancer	0.000166	0.000716	CcSEcCtD
Phenytoin—SCN2A—Axon guidance—RASA1—skin cancer	0.000165	0.00514	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—RASA1—skin cancer	0.000165	0.00514	CbGpPWpGaD
Phenytoin—CYP11B1—Corticotropin-releasing hormone—BRAF—skin cancer	0.000164	0.00509	CbGpPWpGaD
Phenytoin—Diarrhoea—Temozolomide—skin cancer	0.000164	0.000706	CcSEcCtD
Phenytoin—Hypersensitivity—Fluorouracil—skin cancer	0.000162	0.000701	CcSEcCtD
Phenytoin—Dry mouth—Docetaxel—skin cancer	0.000162	0.0007	CcSEcCtD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000162	0.00502	CbGpPWpGaD
Phenytoin—Confusional state—Docetaxel—skin cancer	0.00016	0.000692	CcSEcCtD
Phenytoin—SCN1A—Axon guidance—RASA1—skin cancer	0.00016	0.00495	CbGpPWpGaD
Phenytoin—Anaphylactic shock—Docetaxel—skin cancer	0.000159	0.000687	CcSEcCtD
Phenytoin—SCN8A—Developmental Biology—RASA1—skin cancer	0.000159	0.00493	CbGpPWpGaD
Phenytoin—Dizziness—Temozolomide—skin cancer	0.000158	0.000683	CcSEcCtD
Phenytoin—Infection—Docetaxel—skin cancer	0.000158	0.000682	CcSEcCtD
Phenytoin—Nausea—Dactinomycin—skin cancer	0.000157	0.000678	CcSEcCtD
Phenytoin—Shock—Docetaxel—skin cancer	0.000156	0.000675	CcSEcCtD
Phenytoin—Nervous system disorder—Docetaxel—skin cancer	0.000156	0.000673	CcSEcCtD
Phenytoin—Pruritus—Fluorouracil—skin cancer	0.000156	0.000673	CcSEcCtD
Phenytoin—Thrombocytopenia—Docetaxel—skin cancer	0.000156	0.000672	CcSEcCtD
Phenytoin—Tachycardia—Docetaxel—skin cancer	0.000155	0.00067	CcSEcCtD
Phenytoin—Vomiting—Temozolomide—skin cancer	0.000152	0.000656	CcSEcCtD
Phenytoin—Anorexia—Docetaxel—skin cancer	0.000152	0.000654	CcSEcCtD
Phenytoin—Rash—Temozolomide—skin cancer	0.000151	0.000651	CcSEcCtD
Phenytoin—Diarrhoea—Fluorouracil—skin cancer	0.000151	0.000651	CcSEcCtD
Phenytoin—Dermatitis—Temozolomide—skin cancer	0.000151	0.00065	CcSEcCtD
Phenytoin—Headache—Temozolomide—skin cancer	0.00015	0.000647	CcSEcCtD
Phenytoin—Hypotension—Docetaxel—skin cancer	0.000149	0.000642	CcSEcCtD
Phenytoin—Dizziness—Fluorouracil—skin cancer	0.000146	0.000629	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000145	0.000625	CcSEcCtD
Phenytoin—Insomnia—Docetaxel—skin cancer	0.000144	0.000621	CcSEcCtD
Phenytoin—Paraesthesia—Docetaxel—skin cancer	0.000143	0.000616	CcSEcCtD
Phenytoin—Nausea—Temozolomide—skin cancer	0.000142	0.000613	CcSEcCtD
Phenytoin—Dyspnoea—Docetaxel—skin cancer	0.000142	0.000612	CcSEcCtD
Phenytoin—Somnolence—Docetaxel—skin cancer	0.000141	0.00061	CcSEcCtD
Phenytoin—Vomiting—Fluorouracil—skin cancer	0.00014	0.000605	CcSEcCtD
Phenytoin—Dyspepsia—Docetaxel—skin cancer	0.00014	0.000604	CcSEcCtD
Phenytoin—SCN5A—Developmental Biology—SCN10A—skin cancer	0.000139	0.00433	CbGpPWpGaD
Phenytoin—Rash—Fluorouracil—skin cancer	0.000139	0.0006	CcSEcCtD
Phenytoin—Dermatitis—Fluorouracil—skin cancer	0.000139	0.000599	CcSEcCtD
Phenytoin—Decreased appetite—Docetaxel—skin cancer	0.000138	0.000597	CcSEcCtD
Phenytoin—Headache—Fluorouracil—skin cancer	0.000138	0.000596	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Docetaxel—skin cancer	0.000137	0.000593	CcSEcCtD
Phenytoin—Fatigue—Docetaxel—skin cancer	0.000137	0.000592	CcSEcCtD
Phenytoin—Constipation—Docetaxel—skin cancer	0.000136	0.000587	CcSEcCtD
Phenytoin—Feeling abnormal—Docetaxel—skin cancer	0.000131	0.000566	CcSEcCtD
Phenytoin—Nausea—Fluorouracil—skin cancer	0.000131	0.000565	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—RASA1—skin cancer	0.000129	0.00399	CbGpPWpGaD
Phenytoin—Body temperature increased—Docetaxel—skin cancer	0.000126	0.000543	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—RASA1—skin cancer	0.000123	0.00382	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—RASA1—skin cancer	0.000118	0.00367	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—RASA1—skin cancer	0.000118	0.00367	CbGpPWpGaD
Phenytoin—Hypersensitivity—Docetaxel—skin cancer	0.000117	0.000506	CcSEcCtD
Phenytoin—Asthenia—Docetaxel—skin cancer	0.000114	0.000493	CcSEcCtD
Phenytoin—SCN1A—Developmental Biology—RASA1—skin cancer	0.000114	0.00354	CbGpPWpGaD
Phenytoin—Pruritus—Docetaxel—skin cancer	0.000112	0.000486	CcSEcCtD
Phenytoin—SCN5A—Axon guidance—RASA1—skin cancer	0.000112	0.00348	CbGpPWpGaD
Phenytoin—Diarrhoea—Docetaxel—skin cancer	0.000109	0.00047	CcSEcCtD
Phenytoin—Dizziness—Docetaxel—skin cancer	0.000105	0.000454	CcSEcCtD
Phenytoin—Vomiting—Docetaxel—skin cancer	0.000101	0.000437	CcSEcCtD
Phenytoin—Rash—Docetaxel—skin cancer	0.0001	0.000433	CcSEcCtD
Phenytoin—Dermatitis—Docetaxel—skin cancer	0.0001	0.000432	CcSEcCtD
Phenytoin—Headache—Docetaxel—skin cancer	9.96e-05	0.00043	CcSEcCtD
Phenytoin—Nausea—Docetaxel—skin cancer	9.44e-05	0.000408	CcSEcCtD
Phenytoin—ALB—SLC-mediated transmembrane transport—SLC12A2—skin cancer	8.78e-05	0.00273	CbGpPWpGaD
Phenytoin—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	8.32e-05	0.00258	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—RASA1—skin cancer	8.01e-05	0.00249	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—CDK4—skin cancer	7.79e-05	0.00242	CbGpPWpGaD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	7.25e-05	0.00225	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PLIN2—skin cancer	7.2e-05	0.00224	CbGpPWpGaD
Phenytoin—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	6.65e-05	0.00207	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—CDK4—skin cancer	6.3e-05	0.00196	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—NRAS—skin cancer	6.07e-05	0.00189	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—CDK4—skin cancer	6.03e-05	0.00187	CbGpPWpGaD
Phenytoin—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	5.94e-05	0.00184	CbGpPWpGaD
Phenytoin—Oxaprozin—PTGS2—skin cancer	5.82e-05	0.602	CrCbGaD
Phenytoin—CYP11B1—Metabolism—CSPG4—skin cancer	5.8e-05	0.0018	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—CDK4—skin cancer	5.79e-05	0.0018	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—CDK4—skin cancer	5.79e-05	0.0018	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	5.69e-05	0.00177	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—CDK4—skin cancer	5.58e-05	0.00173	CbGpPWpGaD
Phenytoin—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	5.41e-05	0.00168	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	5.4e-05	0.00168	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PLIN2—skin cancer	5.33e-05	0.00165	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—KRAS—skin cancer	5.23e-05	0.00162	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.98e-05	0.00155	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.95e-05	0.00154	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—NRAS—skin cancer	4.91e-05	0.00152	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—NRAS—skin cancer	4.7e-05	0.00146	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—NRAS—skin cancer	4.51e-05	0.0014	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—NRAS—skin cancer	4.51e-05	0.0014	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.46e-05	0.00139	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.45e-05	0.00138	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—HRAS—skin cancer	4.44e-05	0.00138	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—NRAS—skin cancer	4.35e-05	0.00135	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—NRAS—skin cancer	4.33e-05	0.00135	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—CSPG4—skin cancer	4.3e-05	0.00133	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—IL6—skin cancer	4.25e-05	0.00132	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—KRAS—skin cancer	4.23e-05	0.00131	CbGpPWpGaD
Phenytoin—ALB—Selenium Micronutrient Network—PTGS2—skin cancer	4.21e-05	0.00131	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.05e-05	0.00126	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—KRAS—skin cancer	4.04e-05	0.00126	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—ENO2—skin cancer	3.94e-05	0.00122	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—CDK4—skin cancer	3.93e-05	0.00122	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.91e-05	0.00121	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—KRAS—skin cancer	3.88e-05	0.00121	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—KRAS—skin cancer	3.88e-05	0.00121	CbGpPWpGaD
Phenytoin—Phenylbutazone—PTGS2—skin cancer	3.85e-05	0.398	CrCbGaD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—IL6—skin cancer	3.84e-05	0.00119	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—KRAS—skin cancer	3.75e-05	0.00116	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—KRAS—skin cancer	3.73e-05	0.00116	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—HRAS—skin cancer	3.59e-05	0.00112	CbGpPWpGaD
Phenytoin—ALB—Vitamin B12 Metabolism—IL6—skin cancer	3.55e-05	0.0011	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PLIN2—skin cancer	3.54e-05	0.0011	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—NRAS—skin cancer	3.5e-05	0.00109	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—IL6—skin cancer	3.44e-05	0.00107	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—HRAS—skin cancer	3.44e-05	0.00107	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—NRAS—skin cancer	3.35e-05	0.00104	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—HRAS—skin cancer	3.3e-05	0.00103	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—HRAS—skin cancer	3.3e-05	0.00103	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—IL6—skin cancer	3.29e-05	0.00102	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—NRAS—skin cancer	3.22e-05	0.001	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—NRAS—skin cancer	3.22e-05	0.001	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—HRAS—skin cancer	3.18e-05	0.000988	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—HRAS—skin cancer	3.17e-05	0.000984	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—IL6—skin cancer	3.16e-05	0.000981	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—IL6—skin cancer	3.16e-05	0.000981	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—TP53—skin cancer	3.15e-05	0.000979	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—NRAS—skin cancer	3.11e-05	0.000964	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.09e-05	0.000958	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—NRAS—skin cancer	3.06e-05	0.00095	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—IL6—skin cancer	3.05e-05	0.000946	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—IL6—skin cancer	3.03e-05	0.000942	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—KRAS—skin cancer	3.02e-05	0.000937	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—ENO2—skin cancer	2.92e-05	0.000907	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—IL6—skin cancer	2.89e-05	0.000896	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—KRAS—skin cancer	2.88e-05	0.000896	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CSPG4—skin cancer	2.86e-05	0.000887	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.77e-05	0.000862	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—KRAS—skin cancer	2.77e-05	0.000861	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—KRAS—skin cancer	2.77e-05	0.000861	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—KRAS—skin cancer	2.67e-05	0.00083	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—KRAS—skin cancer	2.63e-05	0.000818	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PLIN2—skin cancer	2.62e-05	0.000814	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—HRAS—skin cancer	2.56e-05	0.000796	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PLIN2—skin cancer	2.56e-05	0.000795	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—IL6—skin cancer	2.45e-05	0.000762	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—HRAS—skin cancer	2.45e-05	0.000761	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—HRAS—skin cancer	2.36e-05	0.000732	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—HRAS—skin cancer	2.36e-05	0.000732	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—IL6—skin cancer	2.35e-05	0.000729	CbGpPWpGaD
Phenytoin—ALB—Selenium Micronutrient Network—IL6—skin cancer	2.29e-05	0.000712	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—ERCC2—skin cancer	2.29e-05	0.000711	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—HRAS—skin cancer	2.27e-05	0.000705	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—IL6—skin cancer	2.25e-05	0.0007	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—IL6—skin cancer	2.25e-05	0.0007	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—HRAS—skin cancer	2.24e-05	0.000695	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PLIN2—skin cancer	2.22e-05	0.000689	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PLIN2—skin cancer	2.21e-05	0.000685	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—NRAS—skin cancer	2.18e-05	0.000678	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—IL6—skin cancer	2.17e-05	0.000675	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—IL6—skin cancer	2.14e-05	0.000665	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CSPG4—skin cancer	2.11e-05	0.000656	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CSPG4—skin cancer	2.06e-05	0.000641	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.98e-05	0.000616	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PLIN2—skin cancer	1.98e-05	0.000615	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—ENO2—skin cancer	1.94e-05	0.000603	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PLIN2—skin cancer	1.93e-05	0.0006	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—KRAS—skin cancer	1.88e-05	0.000583	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PLIN2—skin cancer	1.81e-05	0.000561	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CSPG4—skin cancer	1.79e-05	0.000555	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CSPG4—skin cancer	1.78e-05	0.000552	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—ERCC2—skin cancer	1.7e-05	0.000527	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—HRAS—skin cancer	1.6e-05	0.000496	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CSPG4—skin cancer	1.6e-05	0.000496	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CSPG4—skin cancer	1.56e-05	0.000484	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—IL6—skin cancer	1.53e-05	0.000475	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CSPG4—skin cancer	1.46e-05	0.000452	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ENO2—skin cancer	1.44e-05	0.000446	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ENO2—skin cancer	1.4e-05	0.000436	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PTGS2—skin cancer	1.37e-05	0.000427	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.33e-05	0.000412	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ENO2—skin cancer	1.22e-05	0.000377	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ENO2—skin cancer	1.21e-05	0.000375	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PLIN2—skin cancer	1.19e-05	0.00037	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.18e-05	0.000366	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—ERCC2—skin cancer	1.13e-05	0.00035	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ENO2—skin cancer	1.08e-05	0.000337	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ENO2—skin cancer	1.06e-05	0.000329	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PTGS2—skin cancer	1.02e-05	0.000316	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ENO2—skin cancer	9.89e-06	0.000307	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CSPG4—skin cancer	9.6e-06	0.000298	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.51e-06	0.000295	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.45e-06	0.000293	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.48e-06	0.000263	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ERCC2—skin cancer	8.34e-06	0.000259	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ERCC2—skin cancer	8.15e-06	0.000253	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—NRAS—skin cancer	8.08e-06	0.000251	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.74e-06	0.00024	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ERCC2—skin cancer	7.06e-06	0.000219	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ERCC2—skin cancer	7.02e-06	0.000218	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—KRAS—skin cancer	6.95e-06	0.000216	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTGS2—skin cancer	6.76e-06	0.00021	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ENO2—skin cancer	6.52e-06	0.000203	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ERCC2—skin cancer	6.3e-06	0.000196	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TP53—skin cancer	6.18e-06	0.000192	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ERCC2—skin cancer	6.15e-06	0.000191	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—HRAS—skin cancer	5.91e-06	0.000183	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ERCC2—skin cancer	5.75e-06	0.000178	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTGS2—skin cancer	5e-06	0.000155	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTGS2—skin cancer	4.89e-06	0.000152	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTGS2—skin cancer	4.23e-06	0.000131	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTGS2—skin cancer	4.21e-06	0.000131	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ERCC2—skin cancer	3.79e-06	0.000118	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTGS2—skin cancer	3.78e-06	0.000117	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTGS2—skin cancer	3.69e-06	0.000115	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTGS2—skin cancer	3.45e-06	0.000107	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTGS2—skin cancer	2.27e-06	7.06e-05	CbGpPWpGaD
